1. "2019"
Formats
  1. Journal Article (2145)
  2. Meeting Abstract (2088)
  3. Review (529)
  4. Editorial (275)
  5. Book Section (252)
  6. Guidelines (108)
  7. Correspondence (89)
  8. Research Letter (47)
  9. Conference Paper (44)
  10. Miscellaneous (25)
  11. Book Whole (10)
Groups
  1. Department of Medicine (2451)
  2. Solid Tumor Oncology Division (1409)
  3. GSK Faculty (1204)
  4. Sloan Kettering Institute Postdocs (1163)
  5. Surgery (938)
  6. Hematologic Malignancies, Division of (923)

More Groups

People
  1. Sergio Giralt (97)
  2. Marc Ladanyi (96)
  3. Maria Arcila (84)
  4. Miguel-Angel Perales (82)
  5. Alexander Drilon (76)
  6. David Hyman (74)

More People

Years
  1. 2019 (5612)
Publications
  1. Journal of Clinical Oncology (457)
  2. Blood (268)
  3. Cancer Research (192)
  4. Annals of Oncology (163)
  5. International Journal of Radiation Oncology, Biology, Physics (124)
  6. Modern Pathology (112)

More Publications

Publishers
  1. Elsevier Inc. (696)
  2. American Society of Clinical Oncology (518)
  3. Springer (445)
  4. American Association for Cancer Research (343)
  5. Nature Publishing Group (337)
  6. Oxford University Press (325)

More Publishers

Results (5612)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical impact of ALK mutations in neuroblastoma
    Meeting Abstract

    O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clonal evolution in metastatic rhabdomyosarcoma
    Meeting Abstract

    Kinnaman, M.; Makohon-Moore, A.; Bouvier, N.; Glodzik, D.; Levine, M.; Papaemmanuil, E.; Dela Cruz, F.; Wexler, L.; Kung, A.; Iacobuzio-Donahue, C.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Neurologic complications from central nervous system neuroblastoma metastases
    Meeting Abstract

    Kramer, K.; Khakoo, Y.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Coronary artery disease surveillance for childhood, adolescent and young adult cancer survivors - Recommendations from the International Guideline Harmonization Group
    Meeting Abstract

    Mulrooney, D.; van Dalen, E.; Bardi, E.; Benson, B.; Bergler-Klein, J.; Chen, M. H.; Ehrhardt, M.; Hennewig, U.; Martinsson, U.; Muraca, M.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Relationship between tumor response at therapy completion and prognosis in group III rhabdomyosarcoma: A report from the Children's Oncology Group
    Meeting Abstract

    Lautz, T.; Chi, Y. Y.; Gupta, A. A.; Tian, J.; Wolden, S.; Routh, J. C.; Casey, D.; Dasgupta, R.; Hawkins, D.; Rodeberg, D.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A phase 0 pharmacodynamic and pharmacokinetic study of everolimus in vestibular schwannoma (VS) and meningioma patients
    Meeting Abstract

    Karajannis, M.; Wang, S.; Goldberg, J.; Roland, J. T.; Sen, C.; Placantonakis, D.; Golfinos, J.; Allen, J.; Dunbar, E.; Plotkin, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Correlation between imaging and operative findings in children with pulmonary metastatic osteosarcoma undergoing thoracotomy or thoracoscopy: A Pediatric Surgical Oncology Research Collaborative study
    Meeting Abstract

    Lautz, T.; Doski, J.; Jenkins, T.; Heaton, T.; Mansfield, S.; Aldrink, J. H.; Farooqui, Z.; Rich, B. S.; Glick, R. D.; Silva, A. L.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Prognostic significance of ATRX aberrations in neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Kushner, B.; Cheung, N. K.; Shukla, N.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Larotrectinib efficacy and safety in pediatric patients with TRK fusion cancer
    Meeting Abstract

    Geoerger, B.; van Tilburg, C.; DuBois, S.; Albert, C.; Federman, N.; Nagasubramanian, R.; Doz, F.; Orbach, D.; Bielack, S.; Shukla, N.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Phase 1/2 trial to assess the activity of entrectinib in children and adolescents with recurrent or refractory solid tumors including central nervous system (CNS) tumors
    Meeting Abstract

    Desai, A. V.; Gajjar, A.; Gauvain, K.; Basu, E. M.; Macy, M. E.; Maese, L.; Sabnis, A. J.; Foster, J.; Shusterman, S.; Yoon, J.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save